21st Dec 2011 10:10
Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America (including its territories and possessions, any state of the United States, and the District of Columbia), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.
This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MyCelx Technologies Corporation ("MyCelx" or the "Company").
THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE.
21 December 2011
MYCELX TECHNOLOGIES CORPORATION
("Mycelx Technologies, Inc or the "Company")
(AIM: MYX)
Accident at Gainesville R&D Site
MyCelx Technologies, Inc. regrets to report that an accident occurred at its Research & Development facility in Gainesville, Georgia at 4.30pm EST on December 20, 2011, which tragically resulted in the death of an employee.The Company is taking every appropriate action to support the family of the deceased.The Occupational Health and Safety Administration will be opening an inquiry to determine the cause of the accident. The Company carries all customary insurances. There was minimal damage to the R&D facility; furthermore the Company does not believe that its production operations will be affected.
Enquiries
MyCelx Technologies Corporation
+1 888 306 6843
Connie Mixon - CEO
David Pattillo - CFO
Numis Securities Limited
+44 207 260 1000
Corporate Finance/Nominated Adviser
Alastair Stratton
Stuart Skinner
Corporate Broking
James Black
Ben Stoop
Pelham Bell Pottinger
+44 207 861 3232
Mark Antelme
Nick Lambert
Related Shares:
Mycelx Di S